XML 40 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2015
Stockholders' Equity Note [Abstract]  
Schedule of allocation of share-based compensation expense
The allocation of share-based compensation expense by operating expenses is as follows:
 
 
 
Year Ended December 31,
 
 
 
2015
 
2014
 
 
 
 
 
 
 
Research and development
 
$
240,739
 
$
5,234
 
General and administrative
 
 
619,899
 
 
55,802
 
Sales and marketing
 
 
584,450
 
 
3,376
 
 
 
$
1,445,088
 
$
64,412
 
Schedule of share-based compensation, options granted
A summary of the status of options granted under the plan is presented below as of and for the years ended December 31, 2015 and 2014:
 
 
 
 
 
 
 
Weighted-
 
 
 
 
 
 
 
Weighted-
 
Average
 
 
 
 
 
 
 
Average
 
Remaining
 
Aggregate
 
 
 
Number of
 
Exercise
 
Contractual
 
Intrinsic
 
 
 
Options
 
Price
 
Life (in years)
 
Value
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2014
 
 
20,956
 
 
 
 
 
8.1
 
$
-
 
Granted
 
 
401,053
 
$
0.05
 
 
 
 
 
 
 
Exercised
 
 
(1)
 
$
7.91
 
 
 
 
$
-
 
Forfeited
 
 
(17,736)
 
$
40.34
 
 
 
 
 
 
 
Outstanding at December 31, 2014
 
 
404,272
 
$
1.13
 
 
9.3
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
1,961,637
 
$
2.68
 
 
 
 
 
 
 
Exercised
 
 
(11,472)
 
$
0.20
 
 
 
 
$
19,519
 
Forfeited
 
 
(193,657)
 
$
0.55
 
 
 
 
 
 
 
Outstanding at December 31, 2015
 
 
2,160,780
 
$
2.60
 
 
9.1
 
$
1,575,646
 
Exercisable at December 31, 2015
 
 
432,340
 
$
1.36
 
 
8.6
 
$
632,052
 
Vested and expected to vest
 
 
2,138,606
 
$
2.60
 
 
9.1
 
$
1,555,185
 
Schedule of share-based payment award, Stock Options granted, fair value
The fair value of each option grant was estimated at the date of grant using the Black -Scholes option pricing model based on the assumptions below:
 
 
 
Year Ended December 31,
 
 
 
2015
 
 
2014
 
 
 
 
 
 
 
 
 
 
Annual dividend
 
 
-
 
 
 
-
 
Expected life (in years)
 
 
5.5-6.25
 
 
 
6.25
 
Risk free interest rate
 
 
1.46-1.9
%
 
 
1.84-2.02
%
Expected volatility
 
 
47.7-65.0
%
 
 
60.0
%
Schedule of warrants to purchase shares of common stock
the following warrants to purchase shares of common stock were outstanding:
 
 
 
 
 
 
Outstanding at December 31,
 
 
 
Exercise
 
 
 
 
Issuance
 
Price
 
Expiration
 
2015
 
2014
 
 
August 2007
 
$
7.91
 
 
August 2017
 
 
8,921
 
 
8,921
 
 
March 2008
 
$
790.54
 
 
March 2018
 
 
46
 
 
46
 
 
November 2009
 
$
7.91
 
 
November 2019
 
 
6,674
 
 
6,674
 
 
January 2010
 
$
7.91
 
 
January 2020
 
 
6,674
 
 
6,674
 
 
March 2010
 
$
7.91
 
 
March 2020
 
 
1,277
 
 
1,277
 
 
November 2011
 
$
7.91
 
 
November 2021
 
 
5,213
 
 
5,213
 
 
December 2011
 
$
7.91
 
 
December 2021
 
 
664
 
 
664
 
 
March 2012
 
$
109.90
 
 
March 2019
 
 
4,125
 
 
4,125
 
 
February 2015
 
$
6.60
 
 
February 2025
 
 
225,011
 
 
-
 
 
May 2015
 
$
6.60
 
 
May 2020
 
 
3,457,750
 
 
-
 
 
 
 
 
 
 
 
 
 
 
3,716,355
 
 
33,594